In a report released yesterday, Victoria Lambert from Berenberg Bank maintained a Buy rating on Spire Healthcare (SPI – Research Report), with a price target of p255.00. The company’s shares closed yesterday at p174.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Lambert is ranked #1705 out of 9347 analysts.
Currently, the analyst consensus on Spire Healthcare is a Strong Buy with an average price target of p299.67, which is a 72.22% upside from current levels. In a report released on March 10, J.P. Morgan also maintained a Buy rating on the stock with a £3.09 price target.
The company has a one-year high of p270.50 and a one-year low of p168.20. Currently, Spire Healthcare has an average volume of 659.4K.
Based on the recent corporate insider activity of 7 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of SPI in relation to earlier this year.
Read More on GB:SPI: